Hematopoietic Stem Cell TransplantationBone Marrow TransplantationTransplantation, HomologousGraft vs Host DiseaseBone MarrowTransplantation ConditioningHematologic NeoplasmsBone Marrow CellsTissue DonorsBusulfanCytomegalovirus InfectionsImmunosuppressive AgentsHistocompatibilityTreatment OutcomeLeukemiaBone and BonesHistocompatibility TestingHematopoietic Stem CellsGraft SurvivalWhole-Body IrradiationTransplantation, AutologousRetrospective StudiesTransplantation ChimeraAntiviral AgentsAnemia, AplasticHLA AntigensGraft RejectionKidney TransplantationImmunocompromised HostLymphocyte DepletionHematopoiesisSevere Combined ImmunodeficiencyLeukemia, Myeloid, AcuteRecurrenceOpportunistic InfectionsTime FactorsStem Cell TransplantationPeripheral Blood Stem Cell TransplantationPrecursor Cell Lymphoblastic Leukemia-LymphomaImmunosuppressionTransplantationTransplantsT-LymphocytesMycosesCyclosporineAntigens, CD34Leukemia, Myelogenous, Chronic, BCR-ABL PositiveBone Marrow DiseasesBone RemodelingHaploidyBone Marrow PurgingCytomegalovirusMice, Inbred C57BLAcute DiseaseBone Marrow ExaminationLymphocyte TransfusionAntilymphocyte SerumBone Marrow NeoplasmsGraft vs Leukemia EffectHaplotypesLiving DonorsCyclophosphamideHematologic DiseasesColony-Forming Units AssayFatal OutcomeAspergillosisUnrelated DonorsCord Blood Stem Cell TransplantationCell DifferentiationRadiation ChimeraSurvival AnalysisGanciclovirSurvival RateBone DensitySiblingsPneumonia, ViralMyeloablative AgonistsRemission InductionCombined Modality TherapyDisease-Free SurvivalFetal TherapiesHepatic Veno-Occlusive DiseaseLeukemia, MyeloidTransplantation, IsogeneicMyelodysplastic SyndromesFollow-Up StudiesFlow CytometryCells, CulturedPolymerase Chain ReactionGranulocyte Colony-Stimulating FactorHeart TransplantationPostoperative ComplicationsBone ResorptionCystitisMultiple MyelomaBK VirusNuclear FamilyHerpesvirus 6, HumanBlood CellsLymphoma, Non-Hodgkin